RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 원문제공처
        • 등재정보
        • 학술지명
        • 주제분류
        • 발행연도
        • 작성언어
        • 저자
          펼치기

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        A Microbial Consortium for the Bioremediation of Sulfate-Rich Wastewater Originating from an Edible Oil Industry

        Pascual Javier,Rodríguez Alejandro,Delgado Clara Elena,Rizo-Patróe;n Alejandra,Porcar Manuel,Vilanova Cristina 한국미생물·생명공학회 2022 한국미생물·생명공학회지 Vol.50 No.1

        The effluents from industries processing vegetable oils are extremely rich in sulfates, often exceeding the maximum concentration allowed to release them to the environment. Biological sulfate reduction is a promising alternative for the removal of sulfates in this type of wastewater, which has other particularities such as an acidic pH. The ability to reduce sulfates has been widely described for a particular bacterial group (SRB: sulfate-reducing bacteria), although the reports describing its application for the treatment of sulfate-rich industrial wastewaters are scarce. In this work, we describe the use of a natural SRB-based consortium able to remove above 30% of sulfates in the wastewater from one of the largest edible oil industries in Peru. Metataxonomic analysis was used to analyse the interdependencies established between SRB and the native microbiota present in the wastewater samples, and the performance of the consortium was quantified for different sulfate concentrations in laboratory-scale reactors. Our results pave the way towards the use of this consortium as a low-cost, sustainable alternative for the treatment of larger volumes of wastewater coming from this type of industries.

      • KCI등재

        Prognostic role of genetic biomarkers in clinical progression of prostate cancer

        Maria Jesus Alvarez-Cubero,Luis Javier Martinez-Gonzalez,Maria Saiz,Pedro Carmona-Saez,Juan Carlos Alvarez,Manrique Pascual-Geler,Jose Antonio Lorente,Jose Manuel Cozar 생화학분자생물학회 2015 Experimental and molecular medicine Vol.47 No.-

        The aim of this study was to analyze the use of 12 single-nucleotide polymorphisms in genes ELAC2, RNASEL and MSR1 as biomarkers for prostate cancer (PCa) detection and progression, as well as perform a genetic classification of high-risk patients. A cohort of 451 men (235 patients and 216 controls) was studied. We calculated means of regression analysis using clinical values (stage, prostate-specific antigen, Gleason score and progression) in patients and controls at the basal stage and after a follow-up of 72 months. Significantly different allele frequencies between patients and controls were observed for rs1904577 and rs918 (MSR1 gene) and for rs17552022 and rs5030739 (ELAC2). We found evidence of increased risk for PCa in rs486907 and rs2127565 in variants AA and CC, respectively. In addition, rs627928 (TT–GT), rs486907 (AG) and rs3747531 (CG–CC) were associated with low tumor aggressiveness. Some had a weak linkage, such as rs1904577 and rs2127565, rs4792311 and rs17552022, and rs1904577 and rs918. Our study provides the proof-of-principle that some of the genetic variants (such as rs486907, rs627928 and rs2127565) in genes RNASEL, MSR1 and ELAC2 can be used as predictors of aggressiveness and progression of PCa. In the future, clinical use of these biomarkers, in combination with current ones, could potentially reduce the rate of unnecessary biopsies and specific treatments.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼